CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
High ImpactOriginal article

Bristol Myers jumps as two late-stage trials deliver positive results

Phase 3positivePositive
AI Analysis

Summary

Bristol Myers Squibb announced positive results from two late-stage clinical trials, leading to a stock price increase.

Clinical Trial Data

Phase

3

Primary Endpoint

Met

Importance:8/10
Sentiment:
0.80
Phase 3clinical trialpositive resultslate-stage
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on October 12, 2026 11:17 AM

Read Original